19 December 2020: Database Analysis
Clinical Characteristics and Risk Factors in Coronavirus Disease 2019 Patients with Liver Injury
Dali Zhang 1ABCE* , Zhenyu Zhu 1BDF* , Jingfeng Bi 2C , Danni Feng 1F , Lijuan Zhang 1CD , Hongling Liu 1DE#* , Yinjie Gao 1ADFG#*DOI: 10.12659/MSM.928849
Med Sci Monit 2020; 26:e928849
Table 2 Complications, interventions, and outcomes of COVID-19 patients.
| No. (%) | ||||
|---|---|---|---|---|
| Total (n=40) | Normal ALT (n=24) | Elevated ALT (n=16) | P | |
| Complication | ||||
| Septic shock | 0 (0) | 0 (0) | 0 (0) | – |
| ARDS | 0 (0) | 0 (0) | 0 (0) | – |
| Acute kidney injury | 2 (5%) | 0 (0) | 2 (12.5) | 0.154 |
| Acute cardiac injury | 3 (7.7%) | 0 (0) | 3 (20%) | 0.05 |
| Interventions | ||||
| Antibiotic | 22 (55%) | 9 (37.5%) | 13 (81.3%) | 0.006 |
| Steroid | 17 (42.5%) | 7 (29.2%) | 10 (62.5%) | 0.037 |
| Immunoglobin | 17 (42.5%) | 5 (20.8%) | 12 (75%) | 0.001 |
| Aerosol of Interferon | 38 (95%) | 23 (95.8%) | 15 (93.8%) | 1 |
| Antivirals | 0.606 | |||
| Lopinavir | 31 (77.5%) | 19 (79.2%) | 12 (75.0%) | |
| Arbidol | 3 (7.5%) | 1 (4.2%) | 2 (12.5%) | |
| Outcomes | ||||
| Discharge | 39 (97.5%) | 24 (100%) | 15 (93.75%) | 0.221 |
| Death | 1 (2.5%) | 0 (0) | 1 (6.25%) | 1 |
| ARDS – Acute Respiratory Distress Syndrome. | ||||